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Interactionof Tumor-Associated Macrophages (TAMs) with tumor cells gives insights into tumor progressionand into a
novel therapeutic strategy. In papillarythyroid cancer, patients with tumors containing TAMs had a better prognosis
than patients without TAMs. In prostatic cancer, the reducedof total TAMs can be used as a novel prognostic marker.
In melanoma maligna,high numberof TAMs was statisticallysignificant associated with poor response to treatment.















cell growth directly and or may promote
tumorigenesisindirectlythroughtheinductionof
tumorvasculatures.Macrophagesalsohavebeen















































establisha causal linkage to explain clinical
correlation between macrophages,microvessel
densityandpoorprognosisinbreastcancers.




densityin tumortissueand resultedin a marked
decreaseofpro-angiogenicfactorsreleasedbyTAMs
suchasFGF-j3,TNF-a, MMP-9 andVEGF. This in
turn,ledtoasuppresionbothof tumorangiogenesis,
wth d . 17tumorgro an metastasIS.
CONCLUSION
The roleof TAMs in breastcancerprogression
can either enhanceor inhibit tumor growth,
dependingonthesignalactivationsandsusceptibility
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